|
[1]梁晓峰, 陈园生, 王晓军, 等.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志, 2005, 26 (9) ∶655-658.
|
|
[2]Galan MV, Boyce D, Gordon SC.Current pharmacotherapy for hepa-titis B infection[J].Expert Opin Pharmacother, 2001, 2∶1289-1298.
|
|
[3]Jung MC, Pape GR.Immunology of hepatitis B infection[J].Lancetinfect Dis, 2002, 2∶43-50.
|
|
[4]Bunce M, O'Neill MO, Barnardo MCNM, et al.Phototyping:com-prehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5&DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP) [J].Tissue Antigens, 1995, 46∶355-367.
|
|
[5]Bodmer J G, Marsh S G E, Albert D A, et al.Nomenclatrue for fac-tors of the HLA-A system[J].Tissue Antigen, 1997, 49∶297.
|
|
[6]The MHC sequencing consortium.Complete sequence and gene mapof a human major histocompatibility complex[J].Nature, 1999, 401 (6756) ∶921-3.
|
|
[7]陈兰羽, 陈建杰, 章晓鹰.HLA-A、DRB1等位基因多态性与上海汉族人乙肝后肝硬化相关性研究[J].胃肠病学和肝病学杂志, 2005, 14 (5) ∶487-489.
|
|
[8]Karan MA, Tascioglu NE, Ozturk AO, et al.The role of HLA anti-gens in chronic hepatitis B virus infection[J].J Pak Med Assoc, 2002, 52∶253.
|
|
[9]明利华, 朱源荣Gurtis CH, 等.HLA-A02基因型与中国高发地区肝细胞癌密切关联[J].中国免疫学杂志, 1999, 15∶305-307.
|